These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8759075)

  • 1. Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy. Results of the Diltiazem in Dilated Cardiomyopathy Trial.
    Figulla HR; Gietzen F; Zeymer U; Raiber M; Hegselmann J; Soballa R; Hilgers R
    Circulation; 1996 Aug; 94(3):346-52. PubMed ID: 8759075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arguments supporting the use of calcium antagonists in idiopathic dilated cardiomyopathy: theoretical considerations and clinical results.
    Figulla HR; Kreuzer H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S45-9. PubMed ID: 1707115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
    Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial.
    Wojnicz R; Nowak J; Szyguła-Jurkiewicz B; Wilczek K; Lekston A; Trzeciak P; Nowalany-Kozielska E; Zembala M; Wodniecki J; Poloński L
    Am Heart J; 2006 Oct; 152(4):713.e1-7. PubMed ID: 16996844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of long-term diltiazem treatment in dilated cardiomyopathy.
    Figulla HR; Rechenberg JV; Wiegand V; Soballa R; Kreuzer H
    J Am Coll Cardiol; 1989 Mar; 13(3):653-8. PubMed ID: 2918172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beneficial long-term effects of diltiazem on the course of dilated cardiomyopathy].
    Figulla HR; von Rechenberg J; Wiegand V; Soballa R; Kreuzer H
    Z Kardiol; 1989; 78 Suppl 5():36-42. PubMed ID: 2517156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right ventricular function predicts transplant-free survival in idiopathic dilated cardiomyopathy.
    La Vecchia L; Varotto L; Zanolla L; Spadaro GL; Fontanelli A
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):706-10. PubMed ID: 16932086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Verapamil, diltiazem or nifedipine in severe left ventricular functional disorder? A comparative study of the immediate hemodynamic effects].
    Figulla HR; Kreuzer H; Luig H
    Dtsch Med Wochenschr; 1986 Jan; 111(1):11-4. PubMed ID: 3940829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
    Betocchi S; Piscione F; Losi M A; Pace L; Boccalatte M; Perrone-Filardi P; Cappelli-Bigazzi ; Briguori C; Manganelli F; Ciampi Q; Salvatore M; Chiariello M
    Am J Cardiol; 1996 Aug; 78(4):451-7. PubMed ID: 8752192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
    Waagstein F; Bristow MR; Swedberg K; Camerini F; Fowler MB; Silver MA; Gilbert EM; Johnson MR; Goss FG; Hjalmarson A
    Lancet; 1993 Dec; 342(8885):1441-6. PubMed ID: 7902479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventional study of diltiazem in dilated cardiomyopathy: a report of multiple centre clinical trial in China. Chinese Cooperative Group of Diltiazem Intervention Trial in Dilated Cardiomyopathy.
    Liao YH
    Int J Cardiol; 1998 Mar; 64(1):25-30. PubMed ID: 9579813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy.
    Juillière Y; Barbier G; Feldmann L; Grentzinger A; Danchin N; Cherrier F
    Eur Heart J; 1997 Feb; 18(2):276-80. PubMed ID: 9043845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment.
    Andersson B; Hamm C; Persson S; Wikström G; Sinagra G; Hjalmarson A; Waagstein F
    J Am Coll Cardiol; 1994 May; 23(6):1397-404. PubMed ID: 8176099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
    Engelmeier RS; O'Connell JB; Walsh R; Rad N; Scanlon PJ; Gunnar RM
    Circulation; 1985 Sep; 72(3):536-46. PubMed ID: 3893793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy.
    Suwa M; Ito T; Otake Y; Moriguchi A; Hirota Y; Kawamura K
    Jpn Circ J; 1996 Oct; 60(10):767-73. PubMed ID: 8933239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.